Therion

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

Retrieved on: 
Tuesday, October 26, 2021

We are pleased by the outcome of todays vote and thank our stockholders for supporting the acquisition, said Ken Reali, Chief Executive Officer, Bioventus.

Key Points: 
  • We are pleased by the outcome of todays vote and thank our stockholders for supporting the acquisition, said Ken Reali, Chief Executive Officer, Bioventus.
  • We are excited to welcome the Misonix team to Bioventus.
  • The aggregate share consideration to Misonix stockholders is expected to represent approximately 25% of the combined company on a fully-diluted basis.
  • Readers should also carefully review the risk factors described in other documents that Bioventus and Misonix file from time to time with the SEC.

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

Retrieved on: 
Monday, October 18, 2021

If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.

Key Points: 
  • If the Election Deadline is delayed or extended for any reason, Bioventus and Misonix will promptly announce the delay and, when determined, the rescheduled Election Deadline.
  • Record holders of Misonix common stock should have already received a Letter of Election and Transmittal, which permits the stockholder to make an election as to the type of merger consideration.
  • Misonix stockholders who have no received these instructions are encouraged to contact the bank, brokerage firm or other nominee holding their shares of Misonix common stock as soon as possible.
  • Readers should also carefully review the risk factors described in other documents that Bioventus and Misonix file from time to time with the Commission.